Hasil Pencarian - Hong-Xing Pan

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Immunogenicity consistency and safety with different production scales of recombinant adenovirus type-5 vectored COVID-19 vaccine in healthy adults: a randomized, double-blinded, immunobridging trial

    Immunogenicity consistency and safety with different production scales of recombinant adenovirus type-5 vectored COVID-19 vaccine in healthy adults: a randomized, double-blinded, i... oleh Yan-Fei Wu, Ming-Wei Wei, Rui-Jie Wang, Xi-Ling Guo, Hong-Xing Pan, Ya-Chun Gao, Xiao-Long Li, Xue Wang, Xiao-Min Ma, Peng Wan, Li Zhou, Ya-Wen Zhu, Jing-Xin Li, Feng-Cai Zhu

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants.

    Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants. oleh Feng-Cai Zhu, Zheng-Lun Liang, Fan-Yue Meng, Ying Zeng, Qun-Ying Mao, Kai Chu, Xue-Fang Song, Xin Yao, Jing-Xin Li, Hong Ji, Yi-Ju Zhang, Liang Li, Hong-Xing Pan, Ke Xu, Wei-Ming Dai, Wei-Wei Zhang, Fei Deng, Hua Wang, Jun-Zhi Wang

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults: randomized, double-blind, and placebo-controlled phase 1 and phase 2 clinical trials

    Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults: randomized, double-blind, and placebo-controlled phase 1 and p... oleh Hong-Xing Pan, Jian-Kai Liu, Bao-Ying Huang, Gui-Fan Li, Xian-Yun Chang, Ya-Fei Liu, Wen-Ling Wang, Kai Chu, Jia-Lei Hu, Jing-Xin Li, Dan-Dan Zhu, Jing-Liang Wu, Xiao-Yu Xu, Li Zhang, Meng Wang, Wen-Jie Tan, Wei-Jin Huang, Feng-Cai Zhu, Jing Ni

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials

    Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlle... oleh Fan-Yue Meng, Fan Gao, Si-Yue Jia, Xiang-Hong Wu, Jing-Xin Li, Xi-Ling Guo, Jia-Lu Zhang, Bo-Pei Cui, Zhi-Ming Wu, Ming-Wei Wei, Zhi-Long Ma, Hai-Lin Peng, Hong-Xing Pan, Lin Fan, Jing Zhang, Jiu-Qin Wan, Zhong-Kui Zhu, Xue-Wen Wang, Feng-Cai Zhu

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: